| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeOne Medicines Ltd. | Director | Ordinary Shares | 27.3K | $6.37M | $233.25 | 10 Jun 2025 | Direct |
| BeiGene, Ltd. | Director | Share Option (Right to Buy) | 22.8K | 21 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | 10 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 16:19 |
| BGNE | BeiGene, Ltd. | 21 May 2025 | 2 | $0 | 4 | Director | 23 May 2025, 16:05 |
| BGNE | BeiGene, Ltd. | 05 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 16:31 |
| BGNE | BeiGene, Ltd. | 15 Jun 2023 | 2 | $0 | 4 | Director | 20 Jun 2023, 16:30 |
| BGNE | BeiGene, Ltd. | 22 Aug 2022 | 1 | $0 | 4 | Director | 24 Aug 2022, 16:15 |
| BGNE | BeiGene, Ltd. | 22 Jun 2022 | 2 | $0 | 4 | Director | 24 Jun 2022, 16:15 |
| BGNE | BeiGene, Ltd. | 16 Jun 2021 | 2 | $0 | 4 | Director | 24 Jun 2021, 12:26 |